Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 44

1.

Non-contraceptive applications of the levonorgestrel intrauterine system.

Rodriguez MI, Darney PD.

Int J Womens Health. 2010 Aug 9;2:63-8.

2.

Intrauterine progestins, progesterone antagonists, and receptor modulators: a review of gynecologic applications.

Rodriguez MI, Warden M, Darney PD.

Am J Obstet Gynecol. 2010 May;202(5):420-8. doi: 10.1016/j.ajog.2009.10.863. Epub 2009 Dec 23. Review.

PMID:
20031112
3.

Clinical applications of levonorgestrel-releasing intrauterine system to gynecologic diseases.

Kim ML, Seong SJ.

Obstet Gynecol Sci. 2013 Mar;56(2):67-75. doi: 10.5468/OGS.2013.56.2.67. Epub 2013 Mar 12. Review.

4.

Emerging indications for the levonorgestrel-releasing intrauterine system (LNG-IUS).

Heikinheimo O, Gemzell-Danielsson K.

Acta Obstet Gynecol Scand. 2012 Jan;91(1):3-9. doi: 10.1111/j.1600-0412.2011.01303.x. Epub 2011 Nov 9. Review.

PMID:
22007693
5.

Levonorgestrel-releasing intrauterine system: uses and controversies.

Bahamondes L, Bahamondes MV, Monteiro I.

Expert Rev Med Devices. 2008 Jul;5(4):437-45. doi: 10.1586/17434440.5.4.437. Review.

PMID:
18573044
6.

Laevonorgestrel intra-uterine system--a revolutionary intra-uterine device.

Gupta HP, Singh U, Sinha S.

J Indian Med Assoc. 2007 Jul;105(7):380, 382-5. Review.

PMID:
18178990
7.

Non-contraceptive benefits of hormonal and intrauterine reversible contraceptive methods.

Bahamondes L, Valeria Bahamondes M, Shulman LP.

Hum Reprod Update. 2015 Sep-Oct;21(5):640-51. doi: 10.1093/humupd/dmv023. Epub 2015 Jun 1. Review.

PMID:
26037216
8.

A risk-benefit assessment of the levonorgestrel-releasing intrauterine system.

Sturridge F, Guillebaud J.

Drug Saf. 1996 Dec;15(6):430-40. Review.

PMID:
8968696
9.

Non-contraceptive uses of levonorgestrel-releasing hormone system (LNG-IUS)--a systematic enquiry and overview.

Varma R, Sinha D, Gupta JK.

Eur J Obstet Gynecol Reprod Biol. 2006 Mar 1;125(1):9-28. Epub 2005 Dec 1. Review.

PMID:
16325993
10.

The promise and reality of the intrauterine route for hormone delivery for prevention and therapy of gynecological disease.

Fraser IS.

Contraception. 2007 Jun;75(6 Suppl):S112-7. Epub 2007 Feb 16. Review.

PMID:
17531600
11.

The levonorgestrel intrauterine system: the benefits of reduced bleeding.

Cameron IT.

Eur J Contracept Reprod Health Care. 2001 Jan;6 Suppl 1:27-32. Review.

PMID:
11336431
12.

Efficacy of the levonorgestrel intrauterine system in treating menorrhagia: actualities and ambiguities.

Ikomi A, Pepra EF.

J Fam Plann Reprod Health Care. 2002 Apr;28(2):99-100. Review.

13.

The role of the levonorgestrel-releasing intrauterine device in the management of symptomatic endometriosis.

Vercellini P, ViganĂ² P, Somigliana E.

Curr Opin Obstet Gynecol. 2005 Aug;17(4):359-65. Review.

PMID:
15976541
14.

The levonorgestrel-releasing intrauterine system: an updated review of the contraceptive and noncontraceptive uses.

Chrisman C, Ribeiro P, Dalton VK.

Clin Obstet Gynecol. 2007 Dec;50(4):886-97. Review.

PMID:
17982331
15.

Mirena (Levonorgestrel intrauterine system): a successful novel drug delivery option in contraception.

Rose S, Chaudhari A, Peterson CM.

Adv Drug Deliv Rev. 2009 Aug 10;61(10):808-12. doi: 10.1016/j.addr.2009.04.022. Epub 2009 May 13. Review.

PMID:
19445984
16.

Contraceptive and therapeutic effects of the levonorgestrel intrauterine system: an overview.

Jensen JT.

Obstet Gynecol Surv. 2005 Sep;60(9):604-12. Review.

PMID:
16121115
17.

Levonorgestrel intrauterine system for endometrial protection in women with breast cancer on adjuvant tamoxifen.

Dominick S, Hickey M, Chin J, Su HI.

Cochrane Database Syst Rev. 2015 Dec 9;(12):CD007245. doi: 10.1002/14651858.CD007245.pub3. Review.

PMID:
26649916
18.

Modern management of abnormal uterine bleeding: the levonorgestrel intra-uterine system.

Mansour D.

Best Pract Res Clin Obstet Gynaecol. 2007 Dec;21(6):1007-21. Epub 2007 Jun 1. Review.

PMID:
17544330
19.

Levonorgestrel-releasing intrauterine system in the treatment of heavy menstrual bleeding.

Hurskainen R, Paavonen J.

Curr Opin Obstet Gynecol. 2004 Dec;16(6):487-90. Review.

PMID:
15534445
20.

Hormonal and intrauterine methods for contraception for women aged 25 years and younger.

Tang JH, Lopez LM, Mody S, Grimes DA.

Cochrane Database Syst Rev. 2012 Nov 14;11:CD009805. doi: 10.1002/14651858.CD009805.pub2. Review. Update in: Cochrane Database Syst Rev. 2015;8:CD009805.

PMID:
23152281

Supplemental Content

Support Center